Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	121.55	55.29	44.7	120.39	198.05	19.24
Cash & Short-Term Investments	121.55	55.29	44.7	120.39	198.05	19.24
Cash Growth	62.18%	23.68%	-62.87%	-39.22%	929.49%	-60.61%
Other Receivables	-	2	-	-	-	-
Receivables	-	2	-	-	-	-
Prepaid Expenses	2.17	2.94	3.42	4.11	4.46	1.35
Total Current Assets	123.72	60.23	48.13	124.5	202.52	20.59
Property, Plant & Equipment	8.3	9.06	11.2	13.06	13.9	14.06
Other Long-Term Assets	1.79	1.78	1.6	1.61	1.64	1.66
Total Assets	133.81	71.08	60.93	139.17	218.06	36.32
Accounts Payable	4.1	2.57	1.05	3.13	3.14	5.44
Accrued Expenses	5.62	9.98	10.5	10.33	8.75	13.73
Current Portion of Long-Term Debt	-	-	3.32	6.67	-	2.33
Current Portion of Leases	1.26	1.19	1.1	1	0.88	0.65
Current Unearned Revenue	42.28	13.52	-	-	-	-
Total Current Liabilities	53.26	27.26	15.96	21.12	12.78	22.16
Long-Term Debt	-	-	-	3.17	9.63	7.81
Long-Term Leases	6.3	6.95	8.14	9.23	10.23	11.1
Long-Term Unearned Revenue	28.63	19.26	-	-	-	-
Other Long-Term Liabilities	38.55	-	-	-	-	0.54
Total Liabilities	126.74	53.48	24.1	33.52	32.63	41.6
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	419.93	401.35	362.34	354.75	346.31	1.8
Retained Earnings	-412.86	-383.75	-325.51	-249.11	-160.89	-85.09
Total Common Equity	7.07	17.6	36.83	105.65	185.43	-83.29
Shareholders' Equity	7.07	17.6	36.83	105.65	185.43	-5.29
Total Liabilities & Equity	133.81	71.08	60.93	139.17	218.06	36.32
Total Debt	7.57	8.14	12.55	20.07	20.74	21.89
Net Cash (Debt)	113.99	47.15	32.15	100.32	177.32	-2.65
Net Cash Growth	72.03%	46.64%	-67.95%	-43.42%	-	-
Net Cash Per Share	2.20	0.88	1.17	3.66	31.63	-5.06
Filing Date Shares Outstanding	51.83	51.77	34.47	27.43	27.36	0.81
Total Common Shares Outstanding	51.83	45.76	27.61	27.43	27.36	0.81
Working Capital	70.46	32.97	32.17	103.38	189.74	-1.57
Book Value Per Share	0.14	0.38	1.33	3.85	6.78	-103.39
Tangible Book Value	7.07	17.6	36.83	105.65	185.43	-83.29
Tangible Book Value Per Share	0.14	0.38	1.33	3.85	6.78	-103.39
Machinery	7.02	6.78	6.68	6.45	4.67	3.64
Construction In Progress	-	-	-	0.1	0.54	-
Leasehold Improvements	5.12	5.12	5.12	5.12	5.12	5.09

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q